	Prognostic Value of Histology-specific Ki-67 Labeling Index Cutoffs in Stage I-III Non-small Cell Lung Cancer. In Vivo Kameda Y, Woo T, Matsumura M, Sawazumi T, Arai H, Okudela K, Saito A. PMID: 42957226 [PubMed - indexed for MEDLINE]
	Long-term Disease Control After Probable Endobronchial Small-cell Transformation During Osimertinib Therapy for EGFR-mutant Lung Adenocarcinoma. In Vivo Murayama N, Inomata M, Matsumoto M, Furukawa D, Ichikawa T, Maeda Y, Shinno H, Nakanishi Y, Ishizawa S. PMID: 42957218 [PubMed - indexed for MEDLINE]
	Lung cancer associated with cystic airspaces (LCCA): A comprehensive literature review undertaken as part of the British thoracic oncology group (BTOG) work programme. Lung Cancer Kimani L, Hyde G, O'Dowd E, Johns C, Fitzmaurice GJ, Kar A, Majid M, Jayaprakash KT, Sharman A, Evison M, Bibby A. PMID: 42956674 [PubMed - as supplied by publisher]
	Efficacy and safety of primary granulocyte colony-stimulating factor prophylaxis in patients with small-cell lung cancer receiving first-line platinum-etoposide plus a programmed death-ligand 1 inhibitor: A multicenter retrospective observational study (G-GUARD; TORG-TG2504). Lung Cancer Teranishi S, Misumi Y, Ishihara T, Yamanaka Y, Murata D, Hirose T, Ochiai R, Takagi K, Higashi Y, Hamakawa Y, Ikeda S, Furuya N, Nakahara Y, Miura S, Naoki K. PMID: 42956673 [PubMed - as supplied by publisher]
	Managing patients with advanced non-small cell lung cancer alongside complex comorbidities and frailty: A consensus statement and implications for the United Kingdom health system. J Geriatr Oncol Gomes F, Talbot T, Clayton K, Baijal S, Chitnis M, Kalsi T, Navani N, Fenemore J, Pearce M, Ibrahimo S, Schenk M, Greystoke A, Slavova-Boneva V, Escriu C. PMID: 42956446 [PubMed - as supplied by publisher]
	Discovery of Promising USP21 Small Molecule Inhibitors: A Computational and Artificial Intelligence Modeling-Based Drug Repurposing Study for Non-Small Cell Lung Cancer. Am J Clin Oncol Kanan T, Kanan D, Kandula M. PMID: 42956329 [PubMed - as supplied by publisher]
	Efficacy and safety of curative-intent intensity modulated radiotherapy (IMRT) for inoperable, locally-advanced non-small cell lung cancer: A systematic review. J Cancer Res Ther Shrimali RK, Griffin E, Hee SW, Rogers J, Hutchinson C. PMID: 42955956 [PubMed - indexed for MEDLINE]
	Maoyu Extract Suppresses Non-Small Cell Lung Cancer Progression via PI3K/AKT Signaling Blockade: An Integrated Network Pharmacology and Experimental Validation Study. Appl Biochem Biotechnol Song M, Tan J, Liu L, Zhang Y, Wang B, Zhai Y. PMID: 42955702 [PubMed - as supplied by publisher]
	Local ablative therapy plus systemic treatment versus systemic therapy alone in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis of randomized trials. Int J Clin Oncol Xu Y, Liang Y, Gao W, Yang X, Qin F, Tao Z, Li X, Chen K, Liang Y. PMID: 42955614 [PubMed - as supplied by publisher]
	Molecular mechanisms, functional diversity, and therapeutic implications of HSP90 isoforms in lung cancer. Mol Biol Rep Janani KP, Lalithammbika SK, Praveen Kumar PK. PMID: 42955475 [PubMed - indexed for MEDLINE]
	Measurement properties of the EQ-5D-5L and SF-6D in measuring the health-related quality of life of non-small cell lung cancer patients on active treatments in China. Qual Life Res Wang J, Suo Y, Wang Y, Li Y, Wang L, Guan X, Guo Y, Yang M, Wang H, Zhu H, Liang W, Song N, Xu Y, Wang J, Tang L, Ye Z, Xie F, Li H, Jin X. PMID: 42955471 [PubMed - indexed for MEDLINE]
	Access to lung cancer care in a fragmented insurance-based system: perceived barriers from patients and professionals from private hospitals in Argentina. Support Care Cancer Alonso JP, Roberti J, Ini N, Teijeiro ME, Jorro-Barón F, Hreczuch N, Rodríguez V, Chismechian M, Ranieri S, Suárez-Anzorena I, Ortiz C, Rodríguez AP, García-Elorrio E. PMID: 42955425 [PubMed - indexed for MEDLINE]
	Real-world incidence of interstitial lung disease with enfortumab vedotin plus pembrolizumab or enfortumab vedotin monotherapy in metastatic urothelial carcinoma: a multicenter retrospective study in Japan. Jpn J Clin Oncol Kobari Y, Nakajima N, Saito A, Katsurayama N, Inakawa T, Endo T, Nemoto Y, Nakamura K, Nishimura K, Yoshino M, Ishihara H, Fukuda H, Yoshida K, Shimmura H, Hashimoto Y, Kondo T, Kobayashi H, Takagi T. PMID: 42955067 [PubMed - as supplied by publisher]
	A randomized phase III study optimizing adjuvant osimertinib for resected EGFR-mutant stage II-III non-squamous non-small cell lung cancer: OASIS trial (JACTOP-01). Jpn J Clin Oncol Onodera K, Okada Y, Kudo Y, Yotsukura M, Asakura K, Goto Y, Shiono S, Toyooka S, Maniwa Y, Chen-Yoshikawa TF, Watanabe SI, Taguri M, Seya N, Mizutani T, Kunitoh H, Japan Cancer Treatment Optimization group (JACTOP), Ikeda N. PMID: 42955056 [PubMed - as supplied by publisher]
	Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer: The R-ALPS Randomized Clinical Trial. JAMA Oncol Ji Y, Li Q, Chen L, Pang Q, Jiang O, Chen Y, Wang J, Ge H, Cheng Y, Zhou R, Meng X, Min X, Wang H, Yang H, Xie Y, Zheng A, Li J, Xia B, Hu D, Zhang X, Peng F, Li W, Chen B, Li R, Zheng S, Cai L, Li S, Xu Y, Feng W, Lai X, Sheng L, Sun X, Wang Z, Fang M, Yang Y, Yang Y, Chen M. PMID: 42955021 [PubMed - as supplied by publisher]
	RET fusion-positive non-small cell lung cancer in Sweden: a nationwide registry study. Acta Oncol Äng Eklund E, Brunnström H, Lampa E, Gunnarsson K, Vikström A, Isaksson J, Lamberg K, Botling J, Fagman H, Sayin SI, Wagenius G, Akyurek LM, Berglund A, Sayin VI, Hallqvist A. PMID: 42954455 [PubMed - indexed for MEDLINE]
	Neoadjuvant Therapy for Non-Small Cell Lung Cancer: Recent Advances and Future Directions. Cancer Med An H, Zhao J, Chen W, Li Y, Yan Y, Zhou C, Li R, Yao X, Dong X, Yang X, Hu Y, Chen J, Han C, Bai Y, Xu Y, Li Y. PMID: 42954362 [PubMed - indexed for MEDLINE]
	A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed. Future Oncol He J, Weder W, Chen KN, Hochmair MJ, Shih JY, Lee SY, Lee KY, Nguyen VN, Saeteng S, Liu L, Xing L, Hoang Gia N, Murakami S, Han Y, Saavedra MP, Yoon SH, Teixeira CHA, Escriu C, Martinez-Martí A, Blakely CM, Yatabe Y, Dacic S, Rukazenkov Y, Huang X, Dayal A, Chaft JE, NeoADAURA Investigators. PMID: 42954342 [PubMed - as supplied by publisher]
	Subgroup variations in benefit from telehealth palliative care for advanced lung cancer. J Natl Cancer Inst Post KE, Trotter CS, Munankarmi AM, Chang P, Campbell TC, Rabow MW, Hanson LC, Spoozak L, Grey C, Blackhall L, Chen E, Rhodes R, Cullinan A, Horick NK, Rabideau DJ, El-Jawahri A, Temel JS, Greer JA. PMID: 42954305 [PubMed - as supplied by publisher]
	Environmental PM(2.5) exposure associated with lung cancer in nonsmokers: a narrative review of high-risk groups, mechanisms, and implications for screening. J Toxicol Environ Health B Crit Rev Wang CY, Lim BS, Huang YT. PMID: 42954122 [PubMed - as supplied by publisher]

Articles 1 - 20 / 163104

Page 1 of 8156



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy